SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000928475-04-000084
Filing Date
2004-12-06
Accepted
2004-12-06 09:03:03
Documents
1
Effectiveness Date
2004-12-06

Document Format Files

Seq Description Document Type Size
1 MYLAN LABORATORIES, INC. proxydec6.txt DFAN14A 5278
  Complete submission text file 0000928475-04-000084.txt   7541
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Subject) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: DFAN14A | Act: 34 | File No.: 001-09114 | Film No.: 041185332
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ICAHN ASSOCIATES CORP 767 FIFTH AVE #4700 NEW YORK NY 10153
Business Address C/O ICAHN ASSOCIATES CORP 767 FIFTH AVE #4700 NEW YORK NY 10153 2127024300
ICAHN CARL C ET AL (Filed by) CIK: 0000921669 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000